Daniela P Lage Selected Research

B-Lymphocyte Epitopes (B-Cell Epitope)

6/2022	Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.
1/2022	Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
12/2021	ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
8/2021	Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins.
3/2020	A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis.
1/2019	Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela P Lage Research Topics

Disease

45	Visceral Leishmaniasis (Kala Azar) 06/2022 - 01/2013
29	Infections 07/2022 - 06/2013
24	Leishmaniasis 06/2022 - 01/2014
4	Coinfection 12/2021 - 01/2020
2	HIV Infections (HIV Infection) 12/2021 - 11/2021
2	Chagas Disease (American Trypanosomiasis) 12/2021 - 01/2013
2	Neglected Diseases 06/2020 - 01/2020
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Tuberculosis (Tuberculoses) 12/2021
1	Leprosy (Hansen's Disease) 12/2021
1	Paracoccidioidomycosis (South American Blastomycosis) 12/2021
1	Parasitic Diseases (Parasitic Disease) 02/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Necrosis 01/2019
1	Disease Progression 01/2018
1	Albuminuria 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2013
19	VaccinesIBA 06/2022 - 01/2013
12	AntigensIBA 12/2021 - 01/2014
10	Recombinant ProteinsIBA 06/2022 - 01/2018
9	AntibodiesIBA 01/2022 - 01/2013
6	MicellesIBA 07/2022 - 10/2016
6	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2022 - 01/2019
5	Peptides (Polypeptides)IBA 12/2021 - 06/2013
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2021 - 01/2018
4	Recombinant Fusion ProteinsIBA 12/2021 - 01/2017
4	EpitopesIBA 11/2021 - 01/2014
4	Interleukin-12 (IL 12)IBA 02/2021 - 10/2018
4	Immunoglobulin G (IgG)IBA 02/2021 - 01/2018
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	SaponinsIBA 02/2021 - 07/2017
3	DNA VaccinesIBA 12/2020 - 01/2018
3	Pyridoxal KinaseIBA 12/2020 - 01/2020
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020 - 10/2018
3	Interleukin-4 (Interleukin 4)IBA 01/2019 - 01/2018
2	NaphthoquinonesIBA 02/2022 - 01/2019
2	Poloxamer (Poloxamer 407)IBA 01/2022 - 10/2016
2	A-Form DNA (A-DNA)IBA 02/2021 - 01/2019
2	Virulence Factors (Pathogenicity Factors)IBA 02/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 02/2021 - 01/2019
2	CardenolidesIBA 01/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2018
2	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2020 - 01/2020
2	Liposomes (Liposome)IBA 06/2020 - 11/2018
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2020 - 01/2016
2	NitritesIBA 01/2020 - 01/2018
2	ProhibitinsIBA 01/2020 - 01/2018
2	CytokinesIBA 12/2018 - 01/2016
2	InterferonsIBA 10/2018 - 01/2018
2	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2018 - 10/2016
2	OxygenasesIBA 04/2013 - 01/2013
1	SaltsIBA 07/2022
1	quinolineIBA 07/2022
1	ImmunosorbentsIBA 06/2022
1	EnzymesIBA 06/2022
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	N 30IBA 12/2021
1	Acarbose FDA LinkGeneric 06/2021
1	Ivermectin (Mectizan)FDA Link 02/2021
1	Digitoxin FDA Link 01/2021
1	DigitoxigeninIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	miltefosine (Impavido)IBA 01/2021
1	UCON 50-HB-5100 (F127)IBA 01/2020
1	Leishmania infantum amastin proteinIBA 01/2020
1	Clioquinol (Vioform)FDA Link 01/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2019
1	ProteomeIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Adenosine Monophosphate (AMP)IBA 03/2018
1	InterleukinsIBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 11/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2017
1	Biological ProductsIBA 10/2016
1	PolyproteinsIBA 01/2016
1	Cystatin CIBA 01/2016
1	CreatinineIBA 01/2016
1	ThrombomodulinIBA 01/2016
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016

Therapy/Procedure

4	Therapeutics 02/2022 - 01/2014
1	Aftercare (After-Treatment) 12/2019
1	Drug Therapy (Chemotherapy) 01/2018